CARL ZEISS MEDITEC AG : JP Morgan gives a Sell rating
David Adlington from JP Morgan retains his negative opinion on the stock with a Sell rating. The target price is unchanged at EUR 68.
Source: marketscreener.com
David Adlington News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from David Adlington. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In David Adlington Today - Breaking & Trending Today
Carl Zeiss Meditec just above annual low - JPMorgan skeptical
Despite a very skeptical analyst commentary, Carl Zeiss Meditec shares did not initially mark another low for the year on Friday morning. Although the Jena-based company's shares fell by 2.2 percent...
Source: marketscreener.com
GERRESHEIMER AG : JP Morgan reiterates its Buy rating
In a research note published by David Adlington, JP Morgan advises its customers to buy the stock. The target price continues to be set at EUR 125.70.
Source: marketscreener.com
JPMorgan rates Gerresheimer at 'Overweight' - Target 125.70 euros
The US bank JPMorgan has left its rating for Gerresheimer at Overweight with a target price of 125.70 euros. The takeover of Bormioli initially brings a decent profit contribution at a time when some...
Source: marketscreener.com
Gerresheimer with recovery rally - investors reward takeover
The announcement of a takeover gave Gerresheimer's shares, which had been flagging recently, a boost on Thursday. They recovered by 12 percent in the morning from their three-month low reached the day...
Source: marketscreener.com